Breaking AI & Tech News Analyzed

The End of Purdue Pharma Purdue Pharma, the manufacturer of OxyContin, is slated to be dissolved by the end of the week as a comprehensive legal settlement takes effect. This settlement resolves thousands of lawsuits filed against the company for its role in the opioid crisis, which has claimed over 900,000 lives in the US since 1999. Terms of the Settlement As part of the deal, Purdue Pharma will admit to not having an effective program to prevent its powerful painkillers from being diverted to the black market. The company will also admit to paying doctors to prescribe the drugs and providing information to encourage more opioid prescriptions. The settlement includes $8.3 billion in forfeitures, fines, and penalties, although the company will only pay $225 million to the federal government. Victims' Reactions Many victims of the opioid crisis expressed frustration with the settlement, arguing that it does not provide them with real justice. Some asked the judge to reject the negotiated sentence, stating that it does not hold individual members of the Sackler family accountable. Over 54,000 people with personal injury claims voted to accept the settlement, while about 200 rejected it. The Sackler Family's Role Members of the Sackler family, who own Purdue Pharma, will contribute up to $7 billion over 15 years to fight the opioid crisis. Most of the funds will go to government entities. The settlement also shields family members from lawsuits over opioids for those who agree to the payments. A New Era for Purdue Pharma Under the settlement, Purdue Pharma will cease to exist and be replaced by Knoa Pharma, a new company with a board appointed by states and a mission to combat the opioid crisis. Millions of internal Purdue documents will be made public, and the Sackler family has agreed not to object to having their names removed from institutions they have supported.

In a climate where climate denial, vaccine skepticism and "alternative facts" dominate headlines, Helen Pearson shows that the tide of evidence‑based practice is still rising. Drawing on five years of interviews with over 200 experts, she offers concrete steps for citizens, educators and policymakers to push back against the growing rejection of science. The Rise of Anti‑Science Rhetoric in Politics and Public Health Recent statements from high‑profile figures have amplified doubt: Donald Trump labeled climate change a "con job", while U.S. health secretary Robert F. Kennedy Jr. has slashed 25,000 staff positions at science agencies and publicly undermined vaccines. In the UK, only 40% of respondents believe information about science is "generally true". These attacks echo the 1992 backlash against evidence‑based medicine, when a small group of doctors faced accusations of "dangerous innovation". Numbers Showing Declining Trust and Funding Cuts Public trust in scientific institutions fell from 58% in 2018 to 40% in 2025 (Ipsos UK). U.S. federal science staffing reduced by 12% between 2022‑2025, equating to 25,000 jobs lost. Investment in AI‑driven evidence synthesis reached $126 million in 2025, signaling a counter‑trend toward better access to research. Over 70% of English school leaders now report using research to guide decisions, up from 45% in 2010. Evidence‑based anti‑poverty programmes have impacted an estimated 850 million lives worldwide. Why the Erosion of Evidence Matters Across Sectors The decline in trust is not just an abstract concern; it directly affects health outcomes, climate action and economic policy. When citizens reject vaccine data, disease outbreaks become more likely, increasing healthcare costs. Climate denial stalls emissions‑reduction legislation, jeopardizing global temperature targets. In education, ignoring rigorous studies on tutoring and phonics can widen achievement gaps. What Experts Predict for the Future of Evidence‑Based Decision‑Making AI‑powered synthesis tools like Consensus will become mainstream, allowing anyone to query a database of >250 million papers within seconds. Curricula that embed critical‑thinking and "evidence literacy" are expected to be adopted in at least 60% of OECD schools by 2030. Funding bodies are likely to tie grant eligibility to open‑access data sharing, accelerating transparency. Grass‑roots fact‑checking networks will grow, with community‑led platforms verifying claims in real time. Ultimately, Pearson reminds readers that science is a human endeavour—messy, iterative, and sometimes uncertain—but its collective weight still outpaces anecdote. By asking for evidence, checking peer review, and supporting institutions that champion rigorous research, individuals can help tip the balance toward reason.

The Lead An important Islamic seminary in Kashmir has been declared unlawful under anti-terror laws, prompting backlash from prominent religious and political leaders in the Indian-administered territory. Seminary Under Scrutiny Kashmir Divisional Commissioner Anshul Garg issued the order based on a police dossier that alleged “sustained and covert links” between the seminary, Jamia Siraj-ul-Uloom, and the banned political party Jamaat-e-Islami (JeI), local media reported. The seminary, one of the largest in southern Kashmir, is recognised by the Jammu and Kashmir Board of School Education and has over 800 students. The Data Analysis The seminary has more than 800 students and has “produced doctors, scholars and professionals from homes that could never afford private education”. The move was handed down under the Unlawful Activities Prevention Act (UAPA), a much-criticised law that allows authorities to designate someone a “terrorist” without evidence. The Impact Analysis Leaders in Muslim-majority Kashmir criticised the move as part of an ongoing campaign of overreach by New Delhi. “Declaring Jamia Siraj-ul-Uloom ‘unlawful’ under UAPA is the latest act in a calculated dismantling of Kashmir’s civic life,” wrote Aga Syed Ruhullah Mehdi, a member of Jammu and Kashmir parliament, on X. The Prediction The decision is likely to escalate tensions in the region, where Kashmiri leaders have pushed back against what they describe as a curtailing of religious and other freedoms. Kashmir voters elected local officials in 2024, in the first elections in a decade. However, most powers remain with the New Delhi-appointed lieutenant governor, including control over police, public order and the transfer and posting of officials.

The Detention Crisis in El-Fasher Thousands of people remain detained in poor conditions by the paramilitary Rapid Support Forces (RSF) in el-Fasher in western Sudan, according to a local NGO. The Scale of Detention The Sudan Doctors Network said on Monday that 20 doctors, more than 1,470 civilians, and 907 military personnel are being held in “dire” conditions in multiple detention facilities in the city. 20 doctors detained Over 1,470 civilians detained 907 military personnel detained Conditions in Detention Centers The NGO said in a statement that the RSF is reportedly committing “severe violations” inside the detention centers in el-Fasher, “including killings during torture and interrogation, as well as ethnically motivated killings”. The group reports that 370 women and 426 children are among those held in facilities including Shalla Prison, a children’s hospital, and cargo containers. Humanitarian Crisis The detention centers have faced a cholera outbreak since early February, with poor environmental conditions, a lack of clean water, and malnutrition making the spread of diseases more rampant. The capture of the doctors, alongside a “critical” shortage of medical supplies, has debilitated the health sector, the NGO warned. The Background of the Conflict Sudan descended into conflict three years ago when a rivalry between army chief Abdel Fattah al-Burhan and RSF commander Mohamed Hamdan “Hemedti” Dagalo exploded into all-out war. The RSF and the Sudanese Armed Forces (SAF) have been fighting a vicious civil war since April 2023, which has killed hundreds of thousands and displaced millions to create the “world’s worst humanitarian crisis”, according to the United Nations.

East Darfur, Sudan — Hawa Adam did not expect a childhood illness to kill her son. Ali was two years old when he fell sick on February 25 in Labado, in Sudan’s East Darfur state. He died two days later.“I thought it was one of the ordinary childhood diseases,” the 37-year-old told Al Jazeera. “I never imagined I would lose my child to this epidemic.”Hawa attributes his death to the absence of basic medical care – no vaccination, no qualified doctors. “Most doctors”, she says, “left the area after the war broke out, forcing those with means to seek treatment abroad, in South Sudan or Uganda.”The Collapse of Routine Immunization in East DarfurA measles outbreak has struck several Labado districts since March, killing approximately 70 people and infecting about 1,000 others across 12 residential neighbourhoods, in a population of roughly 12,000, which includes displaced people who arrived during the war, according to Mohamed Abdel Aziz, 32, coordinator of the Labado crisis unit.Those numbers were disputed by East Darfur’s health director, Dr Jabir al-Nadeef, who confirmed to Al Jazeera that measles has struck four districts of the state, but only reported 300 cases and 26 deaths, figures that diverge substantially from those documented by the Labado emergency room.“Vaccines only arrived on April 11 from Chad via UNICEF [United Nations Children’s Fund ], after a prolonged period with no supply, and a vaccination campaign is scheduled to run from April 18 to 24 across the state,” he said.Measles is one of the world’s most contagious diseases, spread by contact with infected nasal or throat secretions or breathing in air that was breathed out by someone with measles, according to the World Health Organization (WHO). Outbreaks can result in severe complications and deaths, especially among young, malnourished children.Transmission: Contact with infected secretions or airborne particles.Current Coverage: Measles vaccination has fallen to 46 percent.Routine Immunization: First dose of diphtheria, tetanus, and pertussis dropped to 48 percent in 2024.Quantifying the Human Cost: Disputed Death Toll and Economic BarriersThe first measles cases in Darfur in the current outbreak were recorded in January, according to UNICEF. It is unfolding against the backdrop of a near-total collapse of public health infrastructure across Darfur, where war has gutted facilities, halted routine vaccination and driven out medical personnel.“We discovered the outbreak by accident,” Abdel Aziz, the coordinator, told Al Jazeera. The teams had been conducting home visits for a fire-prevention workshop when they saw the scale of the outbreak, with almost half of the homes visited having measles cases.In the al-Nil neighbourhood, Ismail Issa, 38, lost his two-year-old daughter Makarem on March 11. His brother Ahmed lost an 18-month-old son, Issa, on March 25. Then Hasan, the three-year-old son of Ismail’s sister Medeeha, died on March 23. All three families live in adjoining homes, and the infection passed between them.Abdel Aziz traced much of the death toll directly to a supply failure. Medicines ran out at the government health centre on February 23. Drugs remain available at private pharmacies, but most residents cannot afford them.Intravenous fluids: 8,000 Sudanese pounds ($20.50).Antibiotics: 10,000 to 15,000 pounds ($25.60 to 38.40).A Public Health Catastrophe UnfoldingAsmaa Jalaluddin, 28, lives in the Dar al-Naim West neighbourhood of Labado with her three children. Her three-year-old daughter, Mashaer Rajab al-Sheikh, fell ill on April 5 with fever, diarrhoea and persistent vomiting. She stopped eating and kept her eyes shut for four days.On April 8, Asmaa took her to the Labado health centre, where she was told her daughter had measles. With no medicines available, she was directed to travel to Shuairiya, 40 kilometres north. There, on April 10, Mashaer received fever reducers and vitamins and slowly began to open her eyes again. She was discharged two days later.Local doctors are now calling for intervention from international health organisations, noting that diseases that had been eliminated are returning.UNICEF spokesperson for Sudan, Eva Hinds, told Al Jazeera that “measles cases continue to be reported across Darfur, with insecurity, displacement, damaged health facilities, and prolonged disruption to routine immunisation all constraining the response.”UNICEF says that a measles-rubella vaccine catch-up campaign has been completed across all localities in Central Darfur and West Darfur, as well as parts of North and South Darfur, reaching approximately 2.1 million children aged nine to 14. Vaccination in remaining areas, including East Darfur, is scheduled for mid to end of April, aiming to reach close to 750,000 children across all nine of the state’s localities.The Long Road to RecoveryFor the families of Labado, the calendar offers little comfort. In the al-Nil neighbourhood, three siblings buried their children within days of one another over the Eid holiday. In Dar al-Naim West, a mother counts the days until her daughter’s 14-day isolation ends. In the Safaa neighbourhood, Hawa Adam has already buried hers.“They could have still been alive,” Hawa Adam said. “Those without money die in Darfur.”

The Postpartum Health Window: A New Prevention StrategyNew mothers who experienced hypertension during pregnancy could significantly reduce their long-term risk of heart attack, stroke, and premature death by implementing daily home blood pressure monitoring, according to a pivotal study from the University of Oxford.Methodology: The Oxford Intervention TrialThe research, published in the journal Hypertension, involved 220 women who had developed hypertension during pregnancy. The study compared two approaches to postpartum care:Standard Care: 108 women received routine care with infrequent blood pressure checks and medication adjustments.Home Monitoring: 112 women used home monitors to check their blood pressure daily. Readings were shared via an app, allowing doctors to adjust medication day-to-day for optimal control.Quantifying the Benefit: Arterial Health and Risk ReductionThe data reveals a tangible physiological improvement in the home monitoring group. Six to nine months after birth, women who managed their blood pressure at home had significantly less stiff arteries compared to those in the standard care group. This reduction in arterial stiffness is clinically significant because it directly correlates with better blood flow and reduced clot formation.Researchers estimate that this specific intervention could reduce the future risk of heart attack or stroke by 10%. Furthermore, the study highlights a broader statistical reality: Harvard researchers found that high blood pressure in pregnancy is linked to a 42% rise in the risk of premature death.Why the Postpartum Period is Critical for Long-Term Cardiovascular HealthProfessor Paul Leeson, who led the study, emphasized that the weeks following birth represent a "powerful and often overlooked opportunity" to protect women's future health. High blood pressure in pregnancy, whether gestational or pre-eclampsia, affects 5-10% of pregnant women and can damage organs immediately.Beyond immediate threats, the condition creates a lasting legacy. Women with a history of hypertensive pregnancy are three times more likely to develop high blood pressure later in life and twice as likely to develop heart disease.The Path Forward: NHS Integration and Future ResearchThe findings are paving the way for a shift in postpartum care standards. Trials are currently underway to determine the most effective methods for rolling out blood pressure monitoring to women after hypertensive pregnancies, with specialist NHS clinics being a primary option.Dr. Sonya Babu-Narayan, clinical director at the British Heart Foundation, noted that this research underscores the importance of the renewed women's health strategy, ensuring that heart health advice is integrated into care at key life stages, from pregnancy through menopause.

The Lead Multiple star players face race against time to recover from injuries sustained weeks before the 2026 FIFA World Cup. Egypt's Mohamed Salah, Spain's Lamine Yamal, and several other key players from top nations are in doubt for the tournament that begins in June. Rising Injury Concerns for World Cup Contenders With the World Cup kicking off in less than two months in Canada, Mexico and the United States, several players find themselves in a race against time to overcome injuries and prove their fitness. Title contenders and former champions Spain, Brazil and Germany will be among those hoping some of their key players recover in time for the tournament, which begins on June 11. Egypt's Salah Hampered by Hamstring Tear The Egyptian and Liverpool forward was in pain as he limped off the field and held his hamstring after being substituted in the league game. While his club manager Arne Slot refused to say whether Salah would miss the rest of Liverpool's season, his national team's director confirmed that the 33-year-old will be out for four weeks. Egyptian football official Ibrahim Hassan confirmed that Salah's club season was over, but said he would be fit for the World Cup, where Egypt face Belgium, New Zealand and Iran in Group G. Spain's Yamal Faces Uncertain World Cup Debut All eyes will be on the award-winning football prodigy, but his World Cup debut has been thrown into doubt after a hamstring injury in his left leg. Barcelona announced that Lamine Yamal's domestic season in Spain is over, but the international forward should be fit to represent Spain at this summer's World Cup. The 18-year-old's participation is still doubtful since it could take four to six weeks to recover as he follows a "conservative treatment plan". Germany's Goalkeeping and Attack Woes The 33-year-old first-choice goalkeeper for Germany has spent more time recovering than playing this year after a severe hamstring injury in February sent him into rehabilitation. German national team coach Julian Nagelsmann told Marc-Andre ter Stegen in March that his chances of playing for the national side were "very slim" and that he had to speed up his recovery to be fit for the tournament in June. Meanwhile, Germany's Serge Gnabry took to social media this week to announce he would be "supporting the boys from home" after suffering a torn adductor muscle in his right thigh. Brazil's Triple Injury Blow Brazil and Chelsea forward Estevao has also been ruled out of the remaining Premier League season after suffering a hamstring injury that left the teen in tears as he was taken off the pitch. Chelsea's interim coach Calum McFarlane expressed his hope for the 19-year-old to make it to the Brazilian squad, though he cautioned there was no guarantee yet. Unlike Estevao, Brazil forward Rodrygo has been decisively ruled out of the World Cup squad due to a torn meniscus and anterior cruciate ligament (ACL) in his right knee. Yet another blow to Brazil comes from a hamstring injury sustained by Eder Militao during Real Madrid's 2–1 win over Deportivo Alaves. France and Japan Also Face Key Player Absences France striker Hugo Ekitike has also been ruled out of the World Cup entirely after tearing his Achilles tendon in April during the Champions League defeat to Paris Saint-Germain. He recently underwent surgery, which Liverpool manager Arne Slot said went well, although recovery and a return to the pitch for the 23-year-old could take as long as 2027. A question mark lingers over the participation of Japan captain and Liverpool defender Wataru Endo, who has not played since sustaining an ankle injury at Sunderland in February. Teammate Takumi Minamino is also in the same situation after rupturing his ACL in December. Race Against Time for Recovery With the tournament fast approaching, national team medical staff and club doctors are working together to create rehabilitation programs that will give these players the best chance of recovering in time. The World Cup's expanded format and compressed schedule due to being hosted across three countries adds additional complexity to recovery timelines, as players may need to be match-fit rather than just medically cleared.

DOJ Moves Select Marijuana Products to Schedule IIIOn Thursday, April 23, 2026, the U.S. Department of Justice clarified that state‑licensed medical marijuana will be shifted from the highly restrictive Schedule I category to Schedule III on the federal drug‑scheduling system. The change does not legalize recreational or broader medical use under federal law, but it lowers the barrier for scientific study.Numbers Behind the Policy Shift57% of U.S. adults support full legalization of marijuana (Pew Research, 2024).One in five Americans reported using marijuana in the past year (CDC).Market researcher BDSA projects $47 billion in legal sales by 2026.Why the Rescheduling Matters for Industry, Law Enforcement, and PatientsMoving products to Schedule III classifies them as having a "moderate to low potential for physical and psychological dependence," which:Allows researchers to apply for federal approvals without the stringent hurdles of Schedule I.Provides doctors with more reliable data on safety and efficacy, as highlighted by Acting Attorney General Todd Blanche.Reduces the disparity between federal and state enforcement, addressing long‑standing concerns about disproportionate arrests.Broader Economic and Political ImplicationsThe decision aligns with a bipartisan trend toward loosening drug restrictions. It follows an executive order by former President Donald Trump and earlier steps by President Joe Biden that stalled before the end of his term. State markets, already legal in 40 states, may see increased investment as federal risk diminishes.Future Outlook: Toward a Full Federal Reclassification?Attorney General Blanche indicated that hearings on a broader reclassification will begin in June 2026. If successful, the federal stance could shift from a punitive model to one focused on public health and economic opportunity, potentially accelerating the projected $47 billion market growth.

The Penalty and the InjuryLamine Yamal scored Barcelona’s first goal in the 40th minute against Celta Vigo, but the celebration was cut short. The 18-year-old immediately signaled distress to the bench, grabbing the back of his left leg and dropping to the ground. He was attended to by doctors, spoke briefly with coach Hansi Flick, and left the field on his own.Restoring the Nine-Point GapBarcelona's narrow win was crucial for their title aspirations. By defeating Celta, the Catalans reclaimed the top spot in La Liga, restoring a nine-point lead over fierce rivals Real Madrid. This advantage was solidified by Real Madrid's own victory over Alaves on Tuesday.World Cup Stakes for the 18-Year-OldThe injury carries significant weight beyond the domestic league. Yamal is set to make his World Cup debut with Spain in June 2026. As a key figure in Spain's attack, his fitness is paramount for the national team's chances in the tournament.Future Outlook: Title Race and FitnessBarcelona faces Getafe on Saturday, while Real Madrid travels to Real Betis on Friday. The injury to Yamal adds a layer of complexity to Hansi Flick's squad management. With the title race still in flux, Barcelona must manage their star player's workload carefully to maintain their lead over Real Madrid and Villarreal.